Retatrutide beat Ozempic on A1c and weight in Lilly's 80-week diabetes study
Lilly says top-dose users lost 20.9% of body weight versus 9.4% on Ozempic, counting only people who stayed on treatment.
Recap by typeshit. Full story at STAT.
Lilly says top-dose users lost 20.9% of body weight versus 9.4% on Ozempic, counting only people who stayed on treatment.
Recap by typeshit. Full story at STAT.
She separates FDA-approved drugs from animal-only and internet-hype compounds, from BPC-157 and Epitalon to retatrutide, and stresses that mechanism isn't proof.
Lilly's experimental weekly shot also lowered blood sugar a bit more than Ozempic in adults with type 2 diabetes, per the shared study report.
Twelve Novo abstracts head to Denver, including a 5,000-patient records study comparing semaglutide and resmetirom, plus four on efruxifermin.
Zeus Hygia reports its berberine extract raised GLP-1 levels in a 14-day, 36-person trial, but warns brands against 'nature's Ozempic' comparisons.
A general tip post warning that weight lost on Ozempic, Wegovy or Mounjaro can include muscle without lifting and enough protein.
New coverage looks at whether organized follow-up help can limit the weight that tends to come back once people come off GLP-1 drugs.
Loading…